By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vernalis PLC (Formerly Known As British Biotech PLC) 

Watlington Road

Oxford    OX4 5LY  United Kingdom
Phone: 01865-748747 Fax: 01865-781047


Key Statistics

Ownership: Public

Web Site: Vernalis
Symbol: VNLPY.PK



ChemGenex Pharmaceuticals Limited  Discovery and development collaboration in anxiety and depression.

Company News
Vernalis (VNLPY.PK) Hit by U.S. Setback for Cough and Cold Drug CCP-08 8/7/2017 8:03:36 AM
Vernalis PLC (VNLPY.PK): Year-End Trading Update And Notice Of Full Year Results 7/19/2017 10:26:18 AM
Servier And Vernalis PLC (VNLPY.PK) Announce Achievement Of 3 Milestones In Their Oncology Drug Discovery Collaboration 4/27/2017 1:52:40 PM
Vernalis PLC (VNLPY.PK): FDA Issues A Complete Response Letter On CCP-07 NDA 4/24/2017 10:49:12 AM
Vernalis PLC (VNLPY.PK) Tanks After the FDA Spurns Cough-Cold Drug Filing 4/21/2017 6:32:29 AM
Vernalis PLC (VNLPY.PK): Unaudited Interim Results For The Six Months Ended 31 December 2016 2/21/2017 9:43:25 AM
Vernalis PLC (VNLPY.PK) Achieves A $3 Million Milestone Payment From Corvus Pharma 2/14/2017 9:26:17 AM
Vernalis PLC (VNLPY.PK): Notice Of Results For Six Months Ended 31/12/2016 1/30/2017 10:59:21 AM
Vernalis PLC (VNLPY.PK): AGM Statement 11/30/2016 10:17:31 AM
Vernalis PLC (VNLPY.PK) Begins Promotion Of MOXATAG (Amoxicillin Extended-Release) Tablets To Primary Care Physicians In The US 10/11/2016 10:44:57 AM